Original article
Irinotecan plus S-1 versus S-1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open-labeled phase 3 trial
Jing Huang, Binghe Xu, Ying Liu, Junxing Huang, Ping Lu, Yi Ba, Lin Wu, Yuxian Bai, Shu Zhang, Jifeng Feng, Ying Cheng, Jie Li, Lu Wen, Xianglin Yuan, Changwu Ma, Chunhong Hu, Qingxia Fan and Xi Wang
[ [Abstract ] [ Abstract 214] [ PDF Full-text 240] [ PubMed] Epub: 4/2/2019 doi:10.1186/s40880-019-0359-7
Original article
Metabolic reprogramming and redox adaptation in sorafenib-resistant leukemia cells: detected by untargeted metabolomics and stable isotope tracing analysis
Xin You, Weiye Jiang, Wenhua Lu, Hui Zhang, Tiantian Yu, Jingyu Tian, Shijun Wen, Guillermo Garcia-Manero, Peng Huang and Yumin Hu
[ [Abstract ] [ Abstract 222] [ PDF Full-text 249] [ PubMed] Epub: 4/2/2019 doi:10.1186/s40880-019-0362-z
Review
Mucinous colorectal adenocarcinoma: clinical pathology and treatment options
Cong Luo, Shuyi Cen, Guojun Ding and Wei Wu
[ [Abstract ] [ Abstract 205] [ PDF Full-text 236] [ PubMed] Epub: 3/29/2019 doi:10.1186/s40880-019-0361-0
Original article
The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study
Sai-Lan Liu, Xue-Song Sun, Xiao-Yun Li, Lin-Quan Tang, Qiu-Yan Chen, Huan-Xin Lin, Yu-Jing Liang, Jin-Jie Yan, Chao Lin, Shan-Shan Guo, Li-Ting Liu, Yang Li, Hao-Jun Xie, Qing-Nan Tang, Hu Liang, Ling Guo and Hai-Qiang Mai
[ [Abstract ] [ Abstract 231] [ PDF Full-text 258] [ PubMed] Epub: 3/29/2019 doi:10.1186/s40880-019-0357-9
Review
Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy
Chang, Emily Kunce Stroup, Zhou Zhang, Brian C.-H. Chiu and Wei Zhang
[ [Abstract ] [ Abstract 210] [ PDF Full-text 237] [ PubMed] Epub: 3/29/2019 doi:10.1186/s40880-019-0356-x
Review
Recent trends from the results of clinical trials on gastric cancer surgery
Takashi Kiyokawa and Takeo Fukagawa
[ [Abstract ] [ Abstract 211] [ PDF Full-text 247] [ PubMed] Epub: 3/27/2019 doi:10.1186/s40880-019-0360-1
Guideline and Consensus
The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer
Feng-Hua Wang, Lin Shen, Jin Li, Zhi-Wei Zhou, Han Liang, Xiao-Tian Zhang, Lei Tang, Yan Xin, Jing Jin, Yu-Jing Zhang, Xiang-Lin Yuan, Tian-Shu Liu, Guo-Xin Li, Qi Wu, Hui-Mian Xu, Jia-Fu Ji, Yuan-Fang Li, Xin Wang, Shan Yu, Hao Liu, Wen-Long Guan and Rui-Hua Xu
[ [Abstract ] [ Abstract 224] [ PDF Full-text 269] [ PubMed] Epub: 3/18/2019 doi:10.1186/s40880-019-0349-9
Research highlight
Disrupting redox stabilizer: a novel therapeutic strategy for colorectal cancer
Dunyaporn Trachootham and Watcharapol Khoonin
[ [Abstract ] [ Abstract 237] [ PDF Full-text 236] [ PubMed] Epub: 3/12/2019 doi:10.1186/s40880-019-0355-y
Letter to the Editor
Skull bone tumor: a review of clinicopathological and neuroimaging characteristics of 426 cases at a single center
Hailong Liu, Xueying Zhang, Mingshan Zhang, Junping Zhang, Weihai Ning,
Angela Yue, Rugang Zhao, Youliang Sun and Chunjiang Yu
[ [Abstract ] [ Abstract 223] [ PDF Full-text 236] [ PubMed] Epub: 3/8/2019 doi:10.1186/s40880-019-0353-0
Original article
Identification of genetic alterations associated with primary resistance to EGFR-TKIs in advanced non-small-cell lung cancer patients with EGFR sensitive mutations
Fang Wang, Xia-Yao Diao, Xiao Zhang, Qiong Shao, Yan-Fen Feng, Xin An and
Hai-Yun Wang
[ [Abstract ] [ Abstract 236] [ PDF Full-text 219] [ PubMed] Epub: 3/2/2019 doi:10.1186/s40880-019-0354-z
